预测辅助化疗反应的非小细胞肺癌mRNA表达特征 - Suppr

Suppr

超能文献

Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

作者信息

Xie Yang, Minna John D

出版信息

J Clin Oncol. 2010 Oct 10;28(29):4404-7. doi: 10.1200/JCO.2010.31.0144. Epub 2010 Sep 7.

DOI:10.1200/JCO.2010.31.0144

PMID:20823415

Abstract

摘要

相似文献

Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

J Clin Oncol. 2010 Oct 10;28(29):4404-7. doi: 10.1200/JCO.2010.31.0144. Epub 2010 Sep 7.

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

J Clin Oncol. 2010 Oct 10;28(29):4417-24. doi: 10.1200/JCO.2009.26.4325. Epub 2010 Sep 7.

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.

BMC Med Genomics. 2012 Jul 2;5:30. doi: 10.1186/1755-8794-5-30.

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

N Engl J Med. 2005 Jun 23;352(25):2589-97. doi: 10.1056/NEJMoa043623.

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Lung Cancer. 2013 Nov;82(2):340-5. doi: 10.1016/j.lungcan.2013.07.020. Epub 2013 Aug 7.

Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.

N Engl J Med. 2005 Jun 23;352(25):2640-2. doi: 10.1056/NEJMe058110.

Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.

J Thorac Oncol. 2011 Jan;6(1):139-47. doi: 10.1097/JTO.0b013e3181fd83a4.

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

N Engl J Med. 2004 Jan 22;350(4):351-60. doi: 10.1056/NEJMoa031644.

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.

PLoS One. 2018 Mar 22;13(3):e0194609. doi: 10.1371/journal.pone.0194609. eCollection 2018.

Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.

Clin Cancer Res. 2007 Feb 1;13(3):994-9. doi: 10.1158/1078-0432.CCR-06-1503.

引用本文的文献

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.

Oncotarget. 2019 Jan 25;10(8):810-824. doi: 10.18632/oncotarget.26574.

Impact of chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.

Mol Clin Oncol. 2017 Sep;7(3):327-335. doi: 10.3892/mco.2017.1340. Epub 2017 Jul 24.

Improving the pathologic evaluation of lung cancer resection specimens.

Transl Lung Cancer Res. 2015 Aug;4(4):432-7. doi: 10.3978/j.issn.2218-6751.2015.07.07.

Advances in adjuvant systemic therapy for non-small-cell lung cancer.

World J Clin Oncol. 2014 Oct 10;5(4):633-45. doi: 10.5306/wjco.v5.i4.633.

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1441-9. doi: 10.1007/s00432-014-1687-2. Epub 2014 Apr 27.

Adaptive prediction model in prospective molecular signature-based clinical studies.

Clin Cancer Res. 2014 Feb 1;20(3):531-9. doi: 10.1158/1078-0432.CCR-13-2127. Epub 2013 Dec 9.

High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.

Oncol Lett. 2013 May;5(5):1461-1466. doi: 10.3892/ol.2013.1209. Epub 2013 Feb 22.

A lung cancer molecular prognostic test ready for prime time.

Lancet. 2012 Mar 3;379(9818):785-7. doi: 10.1016/S0140-6736(12)60154-8.

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.

J Exp Clin Cancer Res. 2011 Dec 29;30(1):115. doi: 10.1186/1756-9966-30-115.

[Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].

Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):211-8. doi: 10.3779/j.issn.1009-3419.2011.03.06.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验